Protein interaction network analysis of mTOR signaling reveals modular organization

被引:2
作者
Wehle, Devin T. [1 ,2 ]
Bass, Carter S. [2 ]
Sulc, Josef [2 ]
Mirzaa, Ghayda [2 ,3 ,4 ]
Smith, Stephen E. P. [1 ,2 ,3 ]
机构
[1] Univ Washington, Grad Program Neurosci, Seattle, WA 98195 USA
[2] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[4] Brotman Baty Inst Precis Med, Seattle, WA USA
关键词
ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; KINASE; INHIBITOR; MUTATIONS; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; SIROLIMUS; PATHWAYS;
D O I
10.1016/j.jbc.2023.105271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mammalian target of rapamycin (mTOR) is a serinethreonine kinase that acts as a central mediator of translation and plays important roles in cell growth, synaptic plasticity, cancer, and a wide range of developmental disorders. The signaling cascade linking lipid kinases (phosphoinositide 3kinases), protein kinases (AKT), and translation initiation complexes (EIFs) to mTOR has been extensively modeled, but does not fully describe mTOR system behavior. Here, we use quantitative multiplex coimmunoprecipitation to monitor a protein interaction network (PIN) composed of 300+ binary interactions among mTOR-related proteins. Using a simple model system of serum-deprived or fresh-media-fed mouse 3T3 fibroblasts, we observed extensive PIN remodeling involving 27+ individual protein interactions after 1 h, despite phosphorylation changes observed after only 5 min. Using small molecule inhibitors of phosphoinositide 3-kinase, AKT, mTOR, MEK and ERK, we define subsets of the PIN, termed "modules", that respond differently to each inhibitor. Using primary fibroblasts from individuals with overgrowth disorders caused by pathogenic PIK3CA or MTOR variants, we find that hyperactivation of mTOR pathway components is reflected in a hyperactive PIN. Our data define a "modular" organization of the mTOR PIN in which coordinated groups of interactions respond to the activation or inhibition of distinct nodes, and demonstrate that kinase inhibitors affect the modular network architecture in a complex manner, inconsistent with simple linear models of signal transduction.
引用
收藏
页数:15
相关论文
共 56 条
[1]   Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation [J].
Brown, Emily A. ;
Neier, Steven C. ;
Neuhauser, Claudia ;
Schrum, Adam G. ;
Smith, Stephen E. P. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (150)
[2]   Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin [J].
Brunn, GJ ;
Hudson, CC ;
Sekulic, A ;
Williams, JM ;
Hosoi, H ;
Houghton, PJ ;
Lawrence, JC ;
Abraham, RT .
SCIENCE, 1997, 277 (5322) :99-101
[3]   RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 [J].
Burnett, PE ;
Barrow, RK ;
Cohen, NA ;
Snyder, SH ;
Sabatini, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1432-1437
[4]   Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16) [J].
Byeon, Seonggyu ;
Kang, Myoung Joo ;
Choi, Yoon Ji ;
Kim, Yu Jung ;
Kim, Miso ;
Yun, Jina ;
Yi, Seong Yoon ;
Kim, Jin Young ;
Kim, Seung Tae ;
Lee, Jeeyun .
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) :3222-3230
[5]   Neurotransmitters Drive Combinatorial Multistate Postsynaptic Density Networks [J].
Coba, Marcelo P. ;
Pocklington, Andrew J. ;
Collins, Mark O. ;
Kopanitsa, Maksym V. ;
Uren, Rachel T. ;
Swamy, Sajani ;
Croning, Mike D. R. ;
Choudhary, Jyoti S. ;
Grant, Seth G. N. .
SCIENCE SIGNALING, 2009, 2 (68) :ra19
[6]   Mammalian Target of Rapamycin Pathway Mutations Cause Hemimegalencephaly and Focal Cortical Dysplasia [J].
D'Gama, Alissa M. ;
Geng, Ying ;
Couto, Javier A. ;
Martin, Beth ;
Boyle, Evan A. ;
LaCoursiere, Christopher M. ;
Hossain, Amer ;
Hatem, Nicole E. ;
Barry, Brenda J. ;
Kwiatkowski, David J. ;
Vinters, Harry V. ;
Barkovich, A. James ;
Shendure, Jay ;
Mathern, Gary W. ;
Walsh, Christopher A. ;
Poduri, Annapurna .
ANNALS OF NEUROLOGY, 2015, 77 (04) :720-725
[7]   Preclinical Pharmacology of AZD5363, an Inhibitor of AKT: Pharmacodynamics, Antitumor Activity, and Correlation of Monotherapy Activity with Genetic Background [J].
Davies, Barry R. ;
Greenwood, Hannah ;
Dudley, Phillippa ;
Crafter, Claire ;
Yu, De-Hua ;
Zhang, Jingchuan ;
Li, Jing ;
Gao, Beirong ;
Ji, Qunsheng ;
Maynard, Juliana ;
Ricketts, Sally-Ann ;
Cross, Darren ;
Cosulich, Sabina ;
Chresta, Christine C. ;
Page, Ken ;
Yates, James ;
Lane, Clare ;
Watson, Rebecca ;
Luke, Richard ;
Ogilvie, Donald ;
Pass, Martin .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) :873-887
[8]   Identification and Characterization of a Novel Constitutional PIK3CA Mutation in a Child Lacking the Typical Segmental Overgrowth of "PIK3CA-Related Overgrowth Spectrum" [J].
Di Donato, Nataliya ;
Rump, Andreas ;
Mirzaa, Ghayda M. ;
Alcantara, Diana ;
Oliver, Antony ;
Schrock, Evelin ;
Dobyns, William B. ;
O'Driscoll, Mark .
HUMAN MUTATION, 2016, 37 (03) :242-245
[9]   PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway [J].
Dokladda, K ;
Green, KA ;
Pan, DA ;
Hardie, DG .
FEBS LETTERS, 2005, 579 (01) :236-240
[10]   A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689